Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Prime Medicine (PRME) Other Operating Expenses (2023)

Prime Medicine's Other Operating Expenses history spans 1 years, with the latest figure at $13.5 million for Q4 2023.

  • For Q4 2023, Other Operating Expenses changed N/A year-over-year to $13.5 million; the TTM value through Sep 2024 reached $13.5 million, changed N/A, while the annual FY2023 figure was $13.5 million, N/A changed from the prior year.
  • Other Operating Expenses reached $13.5 million in Q4 2023 per PRME's latest filing.
  • In the past five years, Other Operating Expenses ranged from a high of $13.5 million in Q4 2023 to a low of $13.5 million in Q4 2023.